CYP2E1 (Cytochrome P450 2E1) variants and mutations
CYP2E1 (also known as Cytochrome P450 2E1) is a human protein-coding gene encoding a cytochrome P450 2E1 protein. It oxidizes ethanol, acetone, anesthetics, and many small xenobiotics and can generate substantial reactive oxygen species during catalysis. Induction by chronic alcohol exposure contributes to toxic metabolite formation and oxidative liver injury. This analysis covers 910 CYP2E1 variants and mutations. Of these, 93% have computational variant effect predictions. Disease context includes Primary amenorrhea, primary ovarian failure, and ovarian dysfunction. Example CYP2E1 variants include M1?, S2C, and S2Y.
Variant analysis overview
- Gene: CYP2E1
- Protein: Cytochrome P450 2E1
- UniProt accession: P05181
- Organism: Homo sapiens
- Variants analyzed: 910
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 676 unspecified-consequence records; 111 missense variants; 87 synonymous variants; 2 in-frame deletions; 26 frameshift variants; 4 stop-gained variants; 3 splice-region variants
- Prediction scores: 844 variants have prediction scores (93% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Primary amenorrhea, primary ovarian failure, ovarian dysfunction, disorder of ear, placenta praevia, hepatocellular carcinoma, breast cancer, gastric cancer, lung carcinoma, lung cancer, breast carcinoma, central nervous system cancer.
Protein structure and variant hotspots
- Protein features: 2 binding sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable CYP2E1 variants
Examples include M1?, S2C, S2Y, S2F, A3S, A3P, A3D, A3V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV9942, cosmic curated COSV99428, Variant assessed as somatic; high impact.
- S2C (p.Ser2Cys), cosmic curated COSV53313
- S2Y (p.Ser2Tyr), gnomAD 10-133527400-C-A, REVEL 0.08, MetaLR 0.19
- S2F (p.Ser2Phe), gnomAD 10-133527400-C-T, REVEL 0.06, MetaLR 0.17
- A3S (p.Ala3Ser), gnomAD 10-133527402-G-T, REVEL 0.08, MetaLR 0.18
- A3P (p.Ala3Pro), gnomAD 10-133527402-G-C, REVEL 0.21, MetaLR 0.32
- A3D (p.Ala3Asp), gnomAD 10-133527403-C-A, REVEL 0.18, MetaLR 0.23
- A3V (p.Ala3Val), gnomAD 10-133527403-C-T, REVEL 0.04, MetaLR 0.10
- A3A (p.Ala3Ala), gnomAD 10-133527404-C-G, CADD 3.16
- A3T (p.Ala3Thr), rs137875795, gnomAD 10-133527509-G-A, CADD 13.20, SIFT 0.76
- L4F (p.Leu4Phe), ExAC rs753713804, gnomAD rs753713804, REVEL 0.22, MetaLR 0.22
- L4R (p.Leu4Arg), Ensembl rs1589952770, MetaLR 0.37, MetaSVM -0.55
- L4I (p.Leu4Ile), gnomAD 10-133527405-C-A, REVEL 0.17, MetaLR 0.22
- L4L (p.Leu4Leu), rs758640808, gnomAD 10-133527407-C-T, CADD 5.19
- G5R (p.Gly5Arg), TOPMed rs1401576094, gnomAD rs1401576094, REVEL 0.36, MetaLR 0.44
- V6A (p.Val6Ala), cosmic curated COSV53315, REVEL 0.12, MetaLR 0.16
- V6F (p.Val6Phe), gnomAD 10-133527411-G-T, REVEL 0.22, MetaLR 0.15
- V6V (p.Val6Val), gnomAD 10-133527413-C-A, CADD 5.34
- T7S (p.Thr7Ser), cosmic curated COSV53313, MetaLR 0.16, MetaSVM -0.98
- T7T (p.Thr7Thr), gnomAD 10-133527416-C-G, CADD 0.32
- V8M (p.Val8Met), TOPMed rs1338671524, gnomAD rs1338671524, REVEL 0.14, MetaLR 0.23
- V8V (p.Val8Val), rs764387026, gnomAD 10-133527419-G-A, CADD 0.36
- A9V (p.Ala9Val), cosmic curated COSV53312, MetaLR 0.36, MetaSVM -0.69
- L10L (p.Leu10Leu), gnomAD 10-133527425-G-C, CADD 11.00
- L11M (p.Leu11Met), 1000Genomes rs543066971, ExAC rs543066971, TOPMed rs543066971, gnomAD rs543066971, REVEL 0.27, MetaLR 0.41
- L11A (p.Leu11Ala), rs1851283349, gnomAD 10-133527424-T-TG, CADD 24.10
- L11P (p.Leu11Pro), gnomAD 10-133527427-T-C, REVEL 0.45, MetaLR 0.45
- V12L (p.Val12Leu), gnomAD rs1457901117, MetaLR 0.22, MetaSVM -0.94
- V12M (p.Val12Met), gnomAD rs1457901117, REVEL 0.13, MetaLR 0.27
- V12V (p.Val12Val), gnomAD 10-133527431-G-T, CADD 3.78
- V12A (p.Val12Ala), rs369847743, gnomAD 10-133527537-T-C, CADD 1.12, SIFT 0.20
- W13L (p.Trp13Leu), ExAC rs757352167, gnomAD rs757352167, REVEL 0.33, MetaLR 0.39
- W13* (p.Trp13Ter), cosmic curated COSV10501
- p.Trp13 Val20del, gnomAD 10-133527421-CCCT, CADD 16.40
- A14V (p.Ala14Val), rs563043306, NCI-TCGA Cosmic COSV5331, cosmic curated COSV53314, 1000Genomes rs563043306, REVEL 0.10, MetaLR 0.08, Variant assessed as somatic; moderate impact.
- A14T (p.Ala14Thr), gnomAD 10-133527435-G-A, REVEL 0.08, MetaLR 0.10
- A14A (p.Ala14Ala), rs375169910, gnomAD 10-133527437-G-A, CADD 8.14
- A15V (p.Ala15Val), TOPMed rs1467974326, gnomAD rs1467974326, REVEL 0.06, MetaLR 0.17
- A15G (p.Ala15Gly), gnomAD 10-133527439-C-G, REVEL 0.09, MetaLR 0.23
- F16F (p.Phe16Phe), gnomAD 10-133527443-C-T, CADD 5.92
- F16L (p.Phe16Leu), rs2133592071, gnomAD 10-133527503-T-C, CADD 15.80, SIFT 0.48
- L17F (p.Leu17Phe), rs367957731, ClinGen CA5767437, ClinVar RCV004240171, 1000Genomes rs367957731, REVEL 0.25, MetaLR 0.44, Uncertain significance, not specified
- L19M (p.Leu19Met), TOPMed rs1851283672, MetaLR 0.27, MetaSVM -0.70
- L19P (p.Leu19Pro), ExAC rs780358119, gnomAD rs780358119, REVEL 0.32, MetaLR 0.31
- L19L (p.Leu19Leu), rs201068922, gnomAD 10-133527452-G-T, CADD 9.52
- L19F (p.Leu19Phe), gnomAD 10-133527563-C-T, CADD 3.23, SIFT 0.33
- V20L (p.Val20Leu), cosmic curated COSV10587, MetaLR 0.15, MetaSVM -0.90
- V20M (p.Val20Met), gnomAD rs1402586895, REVEL 0.10, MetaLR 0.20
- S21F (p.Ser21Phe), cosmic curated COSV53312
- S21S (p.Ser21Ser), rs1466245318, gnomAD 10-133527458-C-T, CADD 11.80
- S21P (p.Ser21Pro), rs1564846644, gnomAD 10-133527554-T-C, CADD 6.89, SIFT 0.25
- M22I (p.Met22Ile), TOPMed rs772430702, REVEL 0.08, MetaLR 0.06
- M22T (p.Met22Thr), rs1336298850, NCI-TCGA Cosmic COSV9942, cosmic curated COSV99429, gnomAD rs1336298850, REVEL 0.11, MetaLR 0.13, Variant assessed as somatic; moderate impact.
- M22V (p.Met22Val), TOPMed rs900694954, MetaLR 0.05, MetaSVM -0.98
- W23* (p.Trp23Ter), gnomAD rs1377320782, CADD 36.00
- W23L (p.Trp23Leu), cosmic curated COSV99429, MetaLR 0.45, MetaSVM 0.17
- R24G (p.Arg24Gly), gnomAD 10-133527465-A-G, REVEL 0.26, MetaLR 0.18
- R24M (p.Arg24Met), gnomAD 10-133527466-G-T, REVEL 0.30, MetaLR 0.19
- R24R (p.Arg24Arg), gnomAD 10-133527467-G-A, CADD 14.70
- R24S (p.Arg24Ser), gnomAD 10-133527467-G-C, REVEL 0.19, MetaLR 0.19
- R24W (p.Arg24Trp), rs1357584379, gnomAD 10-133527521-C-T, CADD 2.51, SIFT 0.00
- Q25K (p.Gln25Lys), gnomAD 10-133527468-C-A, REVEL 0.18, MetaLR 0.21
- Q25* (p.Gln25Ter), gnomAD 10-133527468-C-T, CADD 36.00
- V26G (p.Val26Gly), ExAC rs769059259, gnomAD rs769059259, REVEL 0.15, MetaLR 0.13
- V26M (p.Val26Met), TOPMed rs59868347, gnomAD rs59868347, REVEL 0.03, MetaLR 0.15
- V26V (p.Val26Val), rs1313174406, gnomAD 10-133527473-G-A, CADD 14.70
- H27D (p.His27Asp), gnomAD 10-133527474-C-G, REVEL 0.04, MetaLR 0.18
- H27Q (p.His27Gln), gnomAD 10-133527476-C-G, REVEL 0.04, MetaLR 0.20
- H27Y (p.His27Tyr), rs766438198, gnomAD 10-133527515-C-T, CADD 7.25, SIFT 0.02
- H27N (p.His27Asn), rs776753984, gnomAD 10-133527518-C-A, CADD 6.53, SIFT 0.35
- S28G (p.Ser28Gly), TOPMed rs775675704, gnomAD rs775675704, REVEL 0.11, MetaLR 0.16
- S28I (p.Ser28Ile), NCI-TCGA Cosmic COSV9942, cosmic curated COSV99429, MetaLR 0.25, MetaSVM -0.83, Variant assessed as somatic; moderate impact.
- S28N (p.Ser28Asn), ExAC rs773963522, gnomAD rs773963522, REVEL 0.03, MetaLR 0.14
- S29R (p.Ser29Arg), gnomAD rs1259959217, REVEL 0.07, MetaLR 0.16
- S29T (p.Ser29Thr), gnomAD rs1317965193, REVEL 0.09, MetaLR 0.19
- S29G (p.Ser29Gly), gnomAD 10-133527480-A-G, REVEL 0.07, MetaLR 0.20
- W30* (p.Trp30Ter), Ensembl rs1851284477
- W30C (p.Trp30Cys), TOPMed rs1851284517, NCI-TCGA Cosmic COSV9942, cosmic curated COSV99428, MetaLR 0.37, MetaSVM -0.37, Variant assessed as somatic; moderate impact.
- W30S (p.Trp30Ser), Ensembl rs1851284477, REVEL 0.21, MetaLR 0.27
- N31I (p.Asn31Ile), TOPMed rs1443704595, REVEL 0.09, MetaLR 0.26
- L32V (p.Leu32Val), NCI-TCGA Cosmic COSV5331, cosmic curated COSV53315, MetaLR 0.46, MetaSVM -0.48, Variant assessed as somatic; moderate impact.
- L32L (p.Leu32Leu), gnomAD 10-133527489-C-T, CADD 15.70
- P33R (p.Pro33Arg), NCI-TCGA Cosmic COSV9942, cosmic curated COSV99429, MetaLR 0.80, MetaSVM 0.84, Variant assessed as somatic; moderate impact.
- P33S (p.Pro33Ser), gnomAD rs1260858117, REVEL 0.78, MetaLR 0.78
- P33P (p.Pro33Pro), gnomAD 10-133527494-C-T, CADD 16.40
- P33A (p.Pro33Ala), rs114535864, gnomAD 10-133527569-C-G, CADD 6.15, SIFT 0.42
- P33T (p.Pro33Thr), gnomAD 10-133527569-C-A, CADD 6.13, SIFT 0.32
- P33Q (p.Pro33Gln), gnomAD 10-133527570-C-A, CADD 8.53, SIFT 0.51
- P34T (p.Pro34Thr), gnomAD rs1484033642, REVEL 0.35, MetaLR 0.78
- P34Q (p.Pro34Gln), gnomAD 10-133527491-GC-G, CADD 26.20
- P34L (p.Pro34Leu), gnomAD 10-133527496-C-T, REVEL 0.39, MetaLR 0.78
- G35S (p.Gly35Ser), gnomAD 10-133527498-G-A, REVEL 0.57, MetaLR 0.48
- G35A (p.Gly35Ala), gnomAD 10-133527499-G-C, REVEL 0.52, MetaLR 0.61
- G35* (p.Gly35Ter), gnomAD 10-133527572-G-T, CADD 24.50, SIFT 0.00
- P36A (p.Pro36Ala), ExAC rs747825060, gnomAD rs747825060, REVEL 0.34, MetaLR 0.54
- P36S (p.Pro36Ser), ExAC rs747825060, gnomAD rs747825060, REVEL 0.37, MetaLR 0.67
- F37L (p.Phe37Leu), ExAC rs771599544, gnomAD rs771599544, REVEL 0.12, MetaLR 0.22
- P38L (p.Pro38Leu), ESP rs76271067, ExAC rs76271067, TOPMed rs76271067, gnomAD rs76271067
- P38Q (p.Pro38Gln), cosmic curated COSV99428
- P38R (p.Pro38Arg), ESP rs76271067, ExAC rs76271067, TOPMed rs76271067, gnomAD rs76271067, REVEL 0.26, MetaLR 0.45
- P38S (p.Pro38Ser), NCI-TCGA Cosmic COSV5331, cosmic curated COSV53313, REVEL 0.20, MetaLR 0.51, Variant assessed as somatic; moderate impact.
- P40L (p.Pro40Leu), gnomAD rs979091921, REVEL 0.47, MetaLR 0.62
- P40R (p.Pro40Arg), gnomAD rs979091921, MetaLR 0.69, MetaSVM 0.65
- P40S (p.Pro40Ser), gnomAD 10-133527513-C-T, REVEL 0.46, MetaLR 0.69
- I41V (p.Ile41Val), TOPMed rs1851285042, gnomAD rs1851285042, REVEL 0.07, MetaLR 0.15
- I41T (p.Ile41Thr), rs757431552, gnomAD 10-133527543-T-C, CADD 1.63, SIFT 0.61
- I42M (p.Ile42Met), NCI-TCGA Cosmic COSV5331, cosmic curated COSV53314, REVEL 0.29, MetaLR 0.35, Variant assessed as somatic; moderate impact.
- G43R (p.Gly43Arg), rs759372423, ClinGen CA5767448, cosmic curated COSV99429, ClinVar RCV004367934, REVEL 0.58, MetaLR 0.65, Uncertain significance, not specified
- G43E (p.Gly43Glu), gnomAD 10-133527523-G-A, REVEL 0.56, MetaLR 0.73
- N44D (p.Asn44Asp), cosmic curated COSV53313, MetaLR 0.57, MetaSVM 0.47
- N44K (p.Asn44Lys), 1000Genomes rs527949682, ExAC rs527949682, gnomAD rs527949682, REVEL 0.45, MetaLR 0.55
- L45F (p.Leu45Phe), cosmic curated COSV53315, MetaLR 0.24, MetaSVM -0.61
- L45P (p.Leu45Pro), gnomAD 10-133527529-T-C, REVEL 0.55, MetaLR 0.49
- F46L (p.Phe46Leu), rs2494095419, ClinGen CA378831824, ClinVar RCV004156339, Likely benign, not specified
- F46S (p.Phe46Ser), Ensembl rs1851285262, MetaLR 0.31, MetaSVM -0.56
- Q47E (p.Gln47Glu), TOPMed rs1241054527
- Q47R (p.Gln47Arg), cosmic curated COSV10501, MetaLR 0.31, MetaSVM -0.55
- Q47K (p.Gln47Lys), gnomAD 10-133527534-C-A, REVEL 0.34, MetaLR 0.31
- Q47H (p.Gln47His), gnomAD 10-133527536-G-T, REVEL 0.20, MetaLR 0.33
- E49* (p.Glu49Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E49K (p.Glu49Lys), gnomAD 10-133527524-G-A, CADD 5.53, SIFT 0.27
- N52S (p.Asn52Ser), rs143746211, ClinGen CA5767452, cosmic curated COSV53312, ClinVar RCV004367936, REVEL 0.18, MetaLR 0.19, Uncertain significance, not specified
- N52T (p.Asn52Thr), 1000Genomes rs143746211, ExAC rs143746211, TOPMed rs143746211, gnomAD rs143746211, REVEL 0.21, MetaLR 0.34, Uncertain significance
- I53T (p.Ile53Thr), NCI-TCGA TCGA novel, MetaLR 0.24, MetaSVM -0.80, Variant assessed as somatic; moderate impact.
- P54L (p.Pro54Leu), ExAC rs750499891, gnomAD rs750499891, REVEL 0.21, MetaLR 0.27
- P54S (p.Pro54Ser), cosmic curated COSV10636, TOPMed rs1265920662, gnomAD rs1265920662, REVEL 0.18, MetaLR 0.31
- K55N (p.Lys55Asn), gnomAD 10-133527560-G-T, REVEL 0.09, MetaLR 0.19
- S56C (p.Ser56Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S56F (p.Ser56Phe), TOPMed rs958141259, gnomAD rs958141259, REVEL 0.47, MetaLR 0.49
- S56Y (p.Ser56Tyr), gnomAD 10-133527562-C-A, REVEL 0.48, MetaLR 0.45
- F57L (p.Phe57Leu), ExAC rs756596289, TOPMed rs756596289, gnomAD rs756596289, REVEL 0.16, MetaLR 0.15
- F57S (p.Phe57Ser), rs1564846656, gnomAD 10-133527563-CT-C, CADD 19.60
- T58I (p.Thr58Ile), Ensembl rs1851285683, REVEL 0.25, MetaLR 0.17
- T58S (p.Thr58Ser), ExAC rs780517566, gnomAD rs780517566, REVEL 0.07, MetaLR 0.10
- T58N (p.Thr58Asn), gnomAD 10-133527568-C-A, REVEL 0.18, MetaLR 0.16
- R59=, NCI-TCGA TCGA novel, Variant assessed as somatic; low impact.
- R59P (p.Arg59Pro), ExAC rs779311330, TOPMed rs779311330, gnomAD rs779311330, REVEL 0.45, MetaLR 0.28
- R59Q (p.Arg59Gln), ExAC rs779311330, TOPMed rs779311330, gnomAD rs779311330, REVEL 0.20, MetaLR 0.12, Likely benign, not specified
- R59W (p.Arg59Trp), TOPMed rs1259826192, gnomAD rs1259826192, REVEL 0.37, MetaLR 0.33
- L60V (p.Leu60Val), gnomAD 10-133528481-T-G, REVEL 0.33, MetaLR 0.27
- L60L (p.Leu60Leu), rs2133593090, gnomAD 10-133528481-T-C, CADD 14.50
- A61A (p.Ala61Ala), gnomAD 10-133528486-C-A, CADD 9.35
- Q62E (p.Gln62Glu), ExAC rs768536485, gnomAD rs768536485, REVEL 0.03, MetaLR 0.07
- Q62H (p.Gln62His), NCI-TCGA TCGA novel, gnomAD rs1851298642, REVEL 0.08, MetaLR 0.19, Variant assessed as somatic; moderate impact.
- Q62R (p.Gln62Arg), ExAC rs773302720, gnomAD rs773302720, REVEL 0.20, MetaLR 0.14
- R63C (p.Arg63Cys), ESP rs374426412, ExAC rs374426412, TOPMed rs374426412, gnomAD rs374426412, REVEL 0.29, MetaLR 0.37, Uncertain significance
- R63G (p.Arg63Gly), rs374426412, ClinGen CA5767490, ClinVar RCV004257857, ESP rs374426412, REVEL 0.31, MetaLR 0.31, Uncertain significance, not specified
- R63H (p.Arg63His), rs1354838426, NCI-TCGA Cosmic COSV9942, cosmic curated COSV99429, TOPMed rs1354838426, REVEL 0.16, MetaLR 0.25, Variant assessed as somatic; moderate impact.
- R63R (p.Arg63Arg), rs1554902257, gnomAD 10-133528492-C-T, CADD 12.90
- F64L (p.Phe64Leu), TOPMed rs1294436417, gnomAD rs1294436417, REVEL 0.26, MetaLR 0.18
- F64S (p.Phe64Ser), rs754973375, gnomAD 10-133528492-CT-C, CADD 31.00
- F64F (p.Phe64Phe), gnomAD 10-133528495-C-T, CADD 10.80
- G65R (p.Gly65Arg), gnomAD rs80297454, cosmic curated COSV53312, REVEL 0.57, MetaLR 0.66
- G65W (p.Gly65Trp), cosmic curated COSV53313, MetaLR 0.72, MetaSVM 0.67
- G65G (p.Gly65Gly), rs555927807, gnomAD 10-133528498-G-A, CADD 13.40
- P66Q (p.Pro66Gln), cosmic curated COSV99429, REVEL 0.31, MetaLR 0.56
- P66P (p.Pro66Pro), rs755921307, gnomAD 10-133528501-G-A, CADD 10.60
- V67C (p.Val67Cys), gnomAD 10-133528500-CG-C, CADD 19.90
- F68L (p.Phe68Leu), gnomAD 10-133528507-C-G, REVEL 0.56, MetaLR 0.28
- F68F (p.Phe68Phe), gnomAD 10-133528507-C-T, CADD 16.60
- T69M (p.Thr69Met), rs1324031177, NCI-TCGA Cosmic COSV5331, cosmic curated COSV53313, REVEL 0.61, MetaLR 0.56, Variant assessed as somatic; moderate impact.
- T69R (p.Thr69Arg), NCI-TCGA Cosmic COSV5331, cosmic curated COSV53315, MetaLR 0.56, MetaSVM 0.26, Variant assessed as somatic; moderate impact.
- T69T (p.Thr69Thr), rs77188198, gnomAD 10-133528510-G-A, CADD 10.20
- L70L (p.Leu70Leu), rs1197230343, gnomAD 10-133528513-G-A, CADD 15.20
- Y71H (p.Tyr71His), gnomAD 10-133528514-T-C, REVEL 0.08, MetaLR 0.15
- Y71C (p.Tyr71Cys), gnomAD 10-133528515-A-G, REVEL 0.14, MetaLR 0.44
- Y71Y (p.Tyr71Tyr), rs879876047, gnomAD 10-133528516-C-T, CADD 14.90
- V72L (p.Val72Leu), 1000Genomes rs35844228, ExAC rs35844228, TOPMed rs35844228, gnomAD rs35844228, REVEL 0.06, MetaLR 0.03
- V72M (p.Val72Met), 1000Genomes rs35844228, ExAC rs35844228, TOPMed rs35844228, gnomAD rs35844228, REVEL 0.14, MetaLR 0.07
- G73A (p.Gly73Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G73D (p.Gly73Asp), NCI-TCGA TCGA novel, MetaLR 0.64, MetaSVM 0.44, Variant assessed as somatic; moderate impact.
- S74L (p.Ser74Leu), ExAC rs764575539, TOPMed rs764575539, gnomAD rs764575539, REVEL 0.14, MetaLR 0.16
- S74S (p.Ser74Ser), rs1589953326, gnomAD 10-133528525-G-A, CADD 3.28
- Q75P (p.Gln75Pro), TOPMed rs1589953328, MetaLR 0.19, MetaSVM -0.83
- R76C (p.Arg76Cys), cosmic curated COSV53314, TOPMed rs1329756728, gnomAD rs1329756728, REVEL 0.18, MetaLR 0.45
- R76H (p.Arg76His), rs72559710, UniProt VAR 008360, 1000Genomes rs72559710, ExAC rs72559710, REVEL 0.12, MetaLR 0.39, Benign, in allele CYP2E1*2
- R76L (p.Arg76Leu), 1000Genomes rs72559710, ExAC rs72559710, TOPMed rs72559710, gnomAD rs72559710, MetaLR 0.31, MetaSVM -0.65
- R76P (p.Arg76Pro), 1000Genomes rs72559710, ExAC rs72559710, TOPMed rs72559710, gnomAD rs72559710, REVEL 0.28, MetaLR 0.14
- R76R (p.Arg76Arg), rs1851299348, gnomAD 10-133528531-C-T, CADD 9.10
- M77V (p.Met77Val), Ensembl rs78902616, MetaLR 0.06, MetaSVM -0.87
Public CYP2E1 analysis runs
- CYP2E1 analysis run — CYP2E1 (910 variants) — completed 2026-08-19